Sponsored by:

Nuclear Medicine: Page 242

Nordion's loss increases in FY10
By AuntMinnie.com staff writers
The turbulent medical isotope market took its toll on Nordion in the company's fourth quarter and fiscal 2010 financial results.
January 23, 2011
FDG-NaF 'cocktail' beats FDG in detecting malignant lesions
By Wayne Forrest
Researchers at Stanford University in Stanford, CA, are finding that the combination of FDG and F-18 sodium fluoride (NaF) with PET/CT increases sensitivity for detecting malignant lesions when compared to FDG alone.
January 20, 2011
2011 01 14 17 54 55 781 Lin Slide13 450
FDA panel gives Amyvid PET agent conditional approval
By Wayne Forrest
With a unanimous 16-0 decision, an advisory committee of the U.S. Food and Drug Administration voted on January 20 to conditionally recommend approval of Eli Lilly's PET imaging agent Amyvid (florbetapir) for detecting beta amyloid plaque deposits that could be precursors to Alzheimer's disease.
January 19, 2011
ASRT: RT enrollment drops for 3rd year
By AuntMinnie.com staff writers
The number of first-year students enrolled in radiologic technologist programs in the U.S. dropped for the third straight year in a row, according to the American Society of Radiologic Technologists (ASRT).
January 19, 2011
VC offers 2-for-1 density screening; FDA makes headlines
By Brian Casey
January 19, 2011
Study questions PET efficacy with gliomas
By AuntMinnie.com staff writers
A report from the Institute for Quality and Efficiency in Health Care has determined that "no robust conclusions are possible" on the advantages or disadvantages of using PET to detect recurrences of malignant gliomas.
January 19, 2011
PET with florbetapir may help detect Alzheimer's signs
By Wayne Forrest
PET imaging with the biomarker florbetapir is showing promise in preliminary research to detect the presence of beta amyloid in the brains of living patients to potentially confirm Alzheimer's disease, according to a study in the January 19 issue of the Journal of the American Medical Association.
January 17, 2011
Lantheus promotes Gaffey to CFO
By AuntMinnie.com staff writers
Lantheus Medical Imaging has promoted Robert Gaffey to the position of chief financial officer (CFO).
January 17, 2011
Potential AECL buyer pulls out
By AuntMinnie.com staff writers
The Canadian government's attempt to sell Atomic Energy of Canada (AECL) for more than a year lost a potential buyer last week.
January 16, 2011
GE gets FDA nod for DaTscan
By AuntMinnie.com staff writers
GE Healthcare has received U.S. Food and Drug Administration clearance for its DaTscan (ioflupane I-123 injection) radiopharmaceutical agent.
January 13, 2011
GE touts flutemetamol studies for AD
By AuntMinnie.com staff writers
New clinical research data suggest that GE Healthcare's F-18 flutemetamol radiopharmaceutical could provide accurate identification of beta amyloid plaques, which have been linked to Alzheimer's disease (AD).
January 13, 2011
USP proposes PET drug standards changes
By AuntMinnie.com staff writers
The U.S. Pharmacopeial Convention (USP) has proposed new quality assurance standards for the production and compounding of PET drugs.
January 6, 2011
Previous Page
Page 242 of 440
Next Page